Floatz logo

FERRIC CATION

Iron Deficiencies

Fundación para la Investigación del Hospital Clínico de ValenciaSmall moleculePhase 4 / ApprovedActive
A
80/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
70/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Iron Deficiencies cohort.

Asset / SponsorPhaseRating
Iron Isomaltoside
China-Japan Friendship Hospital
Phase 4BBB
IRON(II) SULPHATE (1:1), HEPTAHYDRATE
Linda Malan
Phase 4BBB
SODIUM FERRIC GLUCONATE
Watson Pharmaceuticals
Phase 4BBB
Iron
Cairo University
Phase 4BB
Iron Hydroxide Polymaltose
Kaplan Medical Center
Phase 3BB

View all 13 →

Same molecule, other indications

FERRIC CATION is also rated in:

restless legs syndromeDormant
BBB
Indicative ·
75 / 100
View asset →
anemiaDormant
BBB
Indicative ·
72 / 100
View asset →
colorectal neoplasmDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →